

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 5.73508064 |
| 2 | regulation of retinoic acid receptor signaling pathway (GO:0048385) | 4.92363795 |
| 3 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 4.10491723 |
| 4 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.06086836 |
| 5 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.90377988 |
| 6 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.90377988 |
| 7 | neutrophil activation involved in immune response (GO:0002283) | 3.82801642 |
| 8 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.79612016 |
| 9 | positive regulation by symbiont of host defense response (GO:0052509) | 3.77251657 |
| 10 | modulation by symbiont of host defense response (GO:0052031) | 3.77251657 |
| 11 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.77251657 |
| 12 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.77251657 |
| 13 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.77251657 |
| 14 | modulation by symbiont of host immune response (GO:0052553) | 3.77251657 |
| 15 | COPI coating of Golgi vesicle (GO:0048205) | 3.71470572 |
| 16 | Golgi transport vesicle coating (GO:0048200) | 3.71470572 |
| 17 | regulation of RIG-I signaling pathway (GO:0039535) | 3.49910962 |
| 18 | ribosomal small subunit assembly (GO:0000028) | 3.43099530 |
| 19 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.39844613 |
| 20 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.37596819 |
| 21 | nuclear envelope reassembly (GO:0031468) | 3.35876485 |
| 22 | mitotic nuclear envelope reassembly (GO:0007084) | 3.35876485 |
| 23 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.28597565 |
| 24 | response to peptidoglycan (GO:0032494) | 3.22412026 |
| 25 | protein maturation by protein folding (GO:0022417) | 3.19832764 |
| 26 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 3.17902429 |
| 27 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.17573978 |
| 28 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.13995676 |
| 29 | positive regulation of T cell apoptotic process (GO:0070234) | 3.11834322 |
| 30 | attachment of spindle microtubules to kinetochore (GO:0008608) | 3.09415410 |
| 31 | immunoglobulin mediated immune response (GO:0016064) | 3.02309188 |
| 32 | negative regulation of interleukin-12 production (GO:0032695) | 2.99626934 |
| 33 | type I interferon signaling pathway (GO:0060337) | 2.98648928 |
| 34 | cellular response to type I interferon (GO:0071357) | 2.98648928 |
| 35 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.98430253 |
| 36 | response to type I interferon (GO:0034340) | 2.97008909 |
| 37 | pentose-phosphate shunt (GO:0006098) | 2.93583929 |
| 38 | viral transcription (GO:0019083) | 2.92739527 |
| 39 | leukocyte aggregation (GO:0070486) | 2.92290515 |
| 40 | amino sugar catabolic process (GO:0046348) | 2.91517137 |
| 41 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.89696660 |
| 42 | regulation of podosome assembly (GO:0071801) | 2.86987554 |
| 43 | positive regulation of interferon-alpha production (GO:0032727) | 2.84359196 |
| 44 | heme biosynthetic process (GO:0006783) | 2.82951729 |
| 45 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.81855223 |
| 46 | cellular response to arsenic-containing substance (GO:0071243) | 2.80093614 |
| 47 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.79524647 |
| 48 | amyloid precursor protein catabolic process (GO:0042987) | 2.79236455 |
| 49 | ribosomal small subunit biogenesis (GO:0042274) | 2.79150874 |
| 50 | B cell mediated immunity (GO:0019724) | 2.76322421 |
| 51 | response to interferon-beta (GO:0035456) | 2.74993707 |
| 52 | NADPH regeneration (GO:0006740) | 2.74939975 |
| 53 | cellular response to interferon-beta (GO:0035458) | 2.74162397 |
| 54 | translational termination (GO:0006415) | 2.73693977 |
| 55 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.71640116 |
| 56 | protein localization to endosome (GO:0036010) | 2.71522270 |
| 57 | pyrimidine-containing compound salvage (GO:0008655) | 2.67589819 |
| 58 | pyrimidine nucleoside salvage (GO:0043097) | 2.67589819 |
| 59 | macrophage activation involved in immune response (GO:0002281) | 2.67313022 |
| 60 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.66378118 |
| 61 | cellular response to exogenous dsRNA (GO:0071360) | 2.65460290 |
| 62 | regulation of interferon-alpha production (GO:0032647) | 2.63167190 |
| 63 | cotranslational protein targeting to membrane (GO:0006613) | 2.61239662 |
| 64 | barbed-end actin filament capping (GO:0051016) | 2.61149841 |
| 65 | pinocytosis (GO:0006907) | 2.61121333 |
| 66 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.60924321 |
| 67 | NIK/NF-kappaB signaling (GO:0038061) | 2.60634662 |
| 68 | glycosphingolipid catabolic process (GO:0046479) | 2.60479170 |
| 69 | cellular response to virus (GO:0098586) | 2.59485264 |
| 70 | protein targeting to ER (GO:0045047) | 2.59210858 |
| 71 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.57311986 |
| 72 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.57065950 |
| 73 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.56920471 |
| 74 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.55354254 |
| 75 | hepatocyte apoptotic process (GO:0097284) | 2.55041171 |
| 76 | regulation of mast cell degranulation (GO:0043304) | 2.54732959 |
| 77 | neutrophil activation (GO:0042119) | 2.53976976 |
| 78 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.51598241 |
| 79 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.51178711 |
| 80 | proteasome assembly (GO:0043248) | 2.50775644 |
| 81 | porphyrin-containing compound biosynthetic process (GO:0006779) | 2.50275465 |
| 82 | folic acid transport (GO:0015884) | 2.49732378 |
| 83 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.49284413 |
| 84 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.49183934 |
| 85 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.48254193 |
| 86 | mitotic metaphase plate congression (GO:0007080) | 2.47940036 |
| 87 | positive regulation of B cell differentiation (GO:0045579) | 2.47776367 |
| 88 | decidualization (GO:0046697) | 2.45802127 |
| 89 | positive regulation of T cell migration (GO:2000406) | 2.44603960 |
| 90 | sequestering of actin monomers (GO:0042989) | 2.44332495 |
| 91 | protein localization to endoplasmic reticulum (GO:0070972) | 2.44053629 |
| 92 | membrane protein intracellular domain proteolysis (GO:0031293) | 2.43834600 |
| 93 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.41543453 |
| 94 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.40464700 |
| 95 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.39802821 |
| 96 | translational elongation (GO:0006414) | 2.39174911 |
| 97 | heme metabolic process (GO:0042168) | 2.38888357 |
| 98 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.38813440 |
| 99 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.38342866 |
| 100 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.36577735 |
| 101 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.36202643 |
| 102 | response to host immune response (GO:0052572) | 2.36202643 |
| 103 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.35887787 |
| 104 | response to host (GO:0075136) | 2.35486452 |
| 105 | response to host defenses (GO:0052200) | 2.35486452 |
| 106 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.35486452 |
| 107 | glucose catabolic process (GO:0006007) | 2.35462467 |
| 108 | detection of other organism (GO:0098543) | 2.35085218 |
| 109 | T cell migration (GO:0072678) | 2.34819596 |
| 110 | protein localization to kinetochore (GO:0034501) | 2.34719057 |
| 111 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.34492479 |
| 112 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.33596448 |
| 113 | respiratory burst (GO:0045730) | 2.33587940 |
| 114 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.32698135 |
| 115 | granulocyte activation (GO:0036230) | 2.32488136 |
| 116 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.32444457 |
| 117 | response to interferon-alpha (GO:0035455) | 2.31543591 |
| 118 | pentose metabolic process (GO:0019321) | 2.31266189 |
| 119 | oligosaccharide catabolic process (GO:0009313) | 2.30603195 |
| 120 | germinal center formation (GO:0002467) | 2.30506929 |
| 121 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.30017202 |
| 122 | protein localization to chromosome, centromeric region (GO:0071459) | 2.29740975 |
| 123 | establishment of chromosome localization (GO:0051303) | 2.29433085 |
| 124 | response to progesterone (GO:0032570) | 2.28784876 |
| 125 | leukocyte apoptotic process (GO:0071887) | 2.28770011 |
| 126 | regulation of T cell chemotaxis (GO:0010819) | 2.28663387 |
| 127 | positive regulation of T cell chemotaxis (GO:0010820) | 2.28663387 |
| 128 | telomere maintenance via recombination (GO:0000722) | 2.28655209 |
| 129 | meiotic chromosome segregation (GO:0045132) | 2.27665769 |
| 130 | regulation of T cell migration (GO:2000404) | 2.27046970 |
| 131 | regulation of B cell differentiation (GO:0045577) | 2.26993193 |
| 132 | regulation of response to interferon-gamma (GO:0060330) | 2.26842697 |
| 133 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.26445418 |
| 134 | positive regulation of interferon-beta production (GO:0032728) | 2.26396234 |
| 135 | negative thymic T cell selection (GO:0045060) | 2.25572116 |
| 136 | positive regulation of isotype switching (GO:0045830) | 2.25380554 |
| 137 | response to laminar fluid shear stress (GO:0034616) | 2.24954869 |
| 138 | negative T cell selection (GO:0043383) | 2.24899440 |
| 139 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.24839309 |
| 140 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.24710633 |
| 141 | regulation of leukocyte degranulation (GO:0043300) | 2.23439349 |
| 142 | positive thymic T cell selection (GO:0045059) | 2.23098629 |
| 143 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.23036903 |
| 144 | glycolipid catabolic process (GO:0019377) | 2.23022835 |
| 145 | regulation of gamma-delta T cell activation (GO:0046643) | 2.22819087 |
| 146 | stress fiber assembly (GO:0043149) | 2.21482930 |
| 147 | response to muramyl dipeptide (GO:0032495) | 2.20745244 |
| 148 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.20569643 |
| 149 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.20051792 |
| 150 | detection of bacterium (GO:0016045) | 2.19501247 |
| 151 | hyaluronan catabolic process (GO:0030214) | 2.19396596 |
| 152 | translational initiation (GO:0006413) | 2.18873486 |
| 153 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.18650612 |
| 154 | modulation by symbiont of host cellular process (GO:0044068) | 2.18426710 |
| 155 | detection of molecule of bacterial origin (GO:0032490) | 2.17698506 |
| 156 | virion assembly (GO:0019068) | 2.17320153 |
| 157 | positive regulation of protein homooligomerization (GO:0032464) | 2.17164893 |
| 158 | interferon-gamma secretion (GO:0072643) | 2.16995994 |
| 159 | negative regulation of viral genome replication (GO:0045071) | 2.16482196 |
| 160 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.16058828 |
| 161 | viral life cycle (GO:0019058) | 2.15525074 |
| 162 | regulation of necroptotic process (GO:0060544) | 2.15101248 |
| 163 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.14514081 |
| 164 | GDP-mannose metabolic process (GO:0019673) | 2.14246985 |
| 165 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.14038261 |
| 166 | virion attachment to host cell (GO:0019062) | 2.13371199 |
| 167 | adhesion of symbiont to host cell (GO:0044650) | 2.13371199 |
| 168 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.13074957 |
| 169 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.12926529 |
| 170 | maturation of SSU-rRNA (GO:0030490) | 2.12436967 |
| 171 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.11836612 |
| 172 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.11721512 |
| 173 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.11622535 |
| 174 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.11235148 |
| 175 | tetrapyrrole biosynthetic process (GO:0033014) | 2.11068999 |
| 176 | cellular response to zinc ion (GO:0071294) | 2.10154267 |
| 177 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.10105437 |
| 178 | myeloid dendritic cell activation (GO:0001773) | 2.10067758 |
| 179 | porphyrin-containing compound metabolic process (GO:0006778) | 2.08791260 |
| 180 | mitotic chromosome condensation (GO:0007076) | 2.08768310 |
| 181 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.08291962 |
| 182 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.07318024 |
| 183 | metaphase plate congression (GO:0051310) | 2.07042204 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.19493362 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.19416514 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.14159536 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.10495413 |
| 5 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.98646763 |
| 6 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.91111613 |
| 7 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.90843719 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.68557583 |
| 9 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.45844484 |
| 10 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.30366962 |
| 11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.28579262 |
| 12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.17680648 |
| 13 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.14673766 |
| 14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.11716035 |
| 15 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.07768137 |
| 16 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.07365608 |
| 17 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.06248705 |
| 18 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.00890528 |
| 19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.99238356 |
| 20 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.90939609 |
| 21 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.90788835 |
| 22 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.86990039 |
| 23 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.86718758 |
| 24 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.85770178 |
| 25 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.83764711 |
| 26 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.83701081 |
| 27 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.81942247 |
| 28 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.79519484 |
| 29 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.77982457 |
| 30 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.77704299 |
| 31 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.75877730 |
| 32 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.75446548 |
| 33 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.74940737 |
| 34 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.73051877 |
| 35 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.70555676 |
| 36 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.70418948 |
| 37 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.67840395 |
| 38 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.67465252 |
| 39 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.64613408 |
| 40 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64385617 |
| 41 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.63425965 |
| 42 | MYB_26560356_Chip-Seq_TH2_Human | 1.60729673 |
| 43 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.60205540 |
| 44 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.59175698 |
| 45 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.58598526 |
| 46 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.58248796 |
| 47 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.58201033 |
| 48 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.57022390 |
| 49 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.56726817 |
| 50 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.54850496 |
| 51 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.52016894 |
| 52 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.51767774 |
| 53 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.50175386 |
| 54 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.49817285 |
| 55 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.49624289 |
| 56 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.49339110 |
| 57 | MYC_22102868_ChIP-Seq_BL_Human | 1.49213962 |
| 58 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.46427610 |
| 59 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.46391531 |
| 60 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.45919852 |
| 61 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.45738057 |
| 62 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.44509608 |
| 63 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.44080890 |
| 64 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.43951271 |
| 65 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.43701054 |
| 66 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.43248280 |
| 67 | * MAF_26560356_Chip-Seq_TH1_Human | 1.42165578 |
| 68 | GATA1_22025678_ChIP-Seq_K562_Human | 1.40071414 |
| 69 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.38899580 |
| 70 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38852266 |
| 71 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.38285824 |
| 72 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.38265068 |
| 73 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.38146720 |
| 74 | MYB_26560356_Chip-Seq_TH1_Human | 1.36230675 |
| 75 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.36090796 |
| 76 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.34293750 |
| 77 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.34273729 |
| 78 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.34273060 |
| 79 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.34185351 |
| 80 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.33964908 |
| 81 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.33852386 |
| 82 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.31108429 |
| 83 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.30993677 |
| 84 | ATF3_27146783_Chip-Seq_COLON_Human | 1.30711638 |
| 85 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30514758 |
| 86 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.30445699 |
| 87 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.28304925 |
| 88 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.27880243 |
| 89 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.27839345 |
| 90 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.25247246 |
| 91 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.23966450 |
| 92 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.23644037 |
| 93 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.19968570 |
| 94 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.19501020 |
| 95 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18881864 |
| 96 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.18745081 |
| 97 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.18499538 |
| 98 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18336614 |
| 99 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.17401885 |
| 100 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.16677729 |
| 101 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.16496430 |
| 102 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.14289629 |
| 103 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.13757161 |
| 104 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.13757161 |
| 105 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.13757161 |
| 106 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13664164 |
| 107 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.13618899 |
| 108 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.10996624 |
| 109 | MAF_26560356_Chip-Seq_TH2_Human | 1.10935500 |
| 110 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10674204 |
| 111 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.10205657 |
| 112 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.07280576 |
| 113 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.07262946 |
| 114 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.06614321 |
| 115 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.06454643 |
| 116 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.05988072 |
| 117 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.05763657 |
| 118 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.05249535 |
| 119 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.04641260 |
| 120 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.03857804 |
| 121 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.03397947 |
| 122 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.02630402 |
| 123 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.00412839 |
| 124 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.00074704 |
| 125 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.99537569 |
| 126 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98487931 |
| 127 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.97841319 |
| 128 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.97298319 |
| 129 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.97001488 |
| 130 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.96955683 |
| 131 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96768832 |
| 132 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.96127841 |
| 133 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.96085977 |
| 134 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.95238247 |
| 135 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.93343836 |
| 136 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.93341176 |
| 137 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.91862884 |
| 138 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.90520489 |
| 139 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90490827 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.19243805 |
| 2 | MP0009785_altered_susceptibility_to | 2.92686700 |
| 3 | MP0008260_abnormal_autophagy | 2.87541951 |
| 4 | MP0003436_decreased_susceptibility_to | 2.72942469 |
| 5 | MP0000685_abnormal_immune_system | 2.70354334 |
| 6 | MP0005671_abnormal_response_to | 2.52046509 |
| 7 | MP0003191_abnormal_cellular_cholesterol | 2.50442401 |
| 8 | MP0005025_abnormal_response_to | 2.29721360 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.24092398 |
| 10 | MP0003693_abnormal_embryo_hatching | 2.23085851 |
| 11 | MP0003763_abnormal_thymus_physiology | 2.21049662 |
| 12 | MP0002148_abnormal_hypersensitivity_rea | 2.19239481 |
| 13 | MP0004510_myositis | 2.14124930 |
| 14 | MP0006082_CNS_inflammation | 2.12498582 |
| 15 | MP0001790_abnormal_immune_system | 2.09646029 |
| 16 | MP0005387_immune_system_phenotype | 2.09646029 |
| 17 | MP0001800_abnormal_humoral_immune | 2.05552009 |
| 18 | MP0009333_abnormal_splenocyte_physiolog | 2.00051538 |
| 19 | MP0002419_abnormal_innate_immunity | 1.96394676 |
| 20 | MP0002452_abnormal_antigen_presenting | 1.96099702 |
| 21 | MP0002405_respiratory_system_inflammati | 1.94108858 |
| 22 | MP0003656_abnormal_erythrocyte_physiolo | 1.92079213 |
| 23 | MP0002723_abnormal_immune_serum | 1.86492102 |
| 24 | MP0001819_abnormal_immune_cell | 1.86330213 |
| 25 | MP0002420_abnormal_adaptive_immunity | 1.85713191 |
| 26 | MP0003724_increased_susceptibility_to | 1.85412047 |
| 27 | MP0002254_reproductive_system_inflammat | 1.84868496 |
| 28 | MP0008438_abnormal_cutaneous_collagen | 1.84449345 |
| 29 | MP0000750_abnormal_muscle_regeneration | 1.84397055 |
| 30 | MP0003077_abnormal_cell_cycle | 1.81383591 |
| 31 | MP0003828_pulmonary_edema | 1.79690435 |
| 32 | MP0002877_abnormal_melanocyte_morpholog | 1.79242185 |
| 33 | MP0002398_abnormal_bone_marrow | 1.78834502 |
| 34 | MP0003186_abnormal_redox_activity | 1.77285343 |
| 35 | MP0001545_abnormal_hematopoietic_system | 1.73013661 |
| 36 | MP0005397_hematopoietic_system_phenotyp | 1.73013661 |
| 37 | MP0002166_altered_tumor_susceptibility | 1.66319312 |
| 38 | MP0004957_abnormal_blastocyst_morpholog | 1.65660042 |
| 39 | MP0000858_altered_metastatic_potential | 1.65573538 |
| 40 | MP0002132_abnormal_respiratory_system | 1.63757811 |
| 41 | MP0000716_abnormal_immune_system | 1.60247683 |
| 42 | MP0002006_tumorigenesis | 1.58227430 |
| 43 | MP0010234_abnormal_vibrissa_follicle | 1.57720412 |
| 44 | MP0001542_abnormal_bone_strength | 1.54637750 |
| 45 | MP0004947_skin_inflammation | 1.54016678 |
| 46 | MP0003111_abnormal_nucleus_morphology | 1.52527981 |
| 47 | MP0003075_altered_response_to | 1.52131491 |
| 48 | MP0002722_abnormal_immune_system | 1.52047517 |
| 49 | MP0000689_abnormal_spleen_morphology | 1.51632808 |
| 50 | MP0004264_abnormal_extraembryonic_tissu | 1.51190618 |
| 51 | MP0001853_heart_inflammation | 1.46360736 |
| 52 | MP0000465_gastrointestinal_hemorrhage | 1.45646536 |
| 53 | MP0002396_abnormal_hematopoietic_system | 1.45548738 |
| 54 | MP0002429_abnormal_blood_cell | 1.44687841 |
| 55 | MP0001533_abnormal_skeleton_physiology | 1.43916958 |
| 56 | MP0005464_abnormal_platelet_physiology | 1.41372819 |
| 57 | MP0001346_abnormal_lacrimal_gland | 1.40470858 |
| 58 | MP0010155_abnormal_intestine_physiology | 1.40215725 |
| 59 | MP0004233_abnormal_muscle_weight | 1.39996110 |
| 60 | MP0002796_impaired_skin_barrier | 1.38945211 |
| 61 | MP0008004_abnormal_stomach_pH | 1.35649749 |
| 62 | MP0001845_abnormal_inflammatory_respons | 1.35006964 |
| 63 | MP0010094_abnormal_chromosome_stability | 1.34357564 |
| 64 | MP0008007_abnormal_cellular_replicative | 1.34210223 |
| 65 | MP0000490_abnormal_crypts_of | 1.33319665 |
| 66 | MP0000343_altered_response_to | 1.31620746 |
| 67 | MP0009278_abnormal_bone_marrow | 1.30971226 |
| 68 | MP0000703_abnormal_thymus_morphology | 1.28570613 |
| 69 | MP0002019_abnormal_tumor_incidence | 1.27911340 |
| 70 | MP0009053_abnormal_anal_canal | 1.27786434 |
| 71 | MP0003453_abnormal_keratinocyte_physiol | 1.26591429 |
| 72 | MP0005257_abnormal_intraocular_pressure | 1.26418983 |
| 73 | MP0009840_abnormal_foam_cell | 1.25274086 |
| 74 | MP0003448_altered_tumor_morphology | 1.25223992 |
| 75 | MP0005451_abnormal_body_composition | 1.24560093 |
| 76 | MP0003172_abnormal_lysosome_physiology | 1.19656358 |
| 77 | MP0010352_gastrointestinal_tract_polyps | 1.19211917 |
| 78 | MP0003091_abnormal_cell_migration | 1.19204835 |
| 79 | MP0005408_hypopigmentation | 1.17871476 |
| 80 | MP0003279_aneurysm | 1.17058331 |
| 81 | MP0006054_spinal_hemorrhage | 1.17029246 |
| 82 | MP0004808_abnormal_hematopoietic_stem | 1.16626011 |
| 83 | MP0008469_abnormal_protein_level | 1.09233249 |
| 84 | MP0000516_abnormal_urinary_system | 1.07918592 |
| 85 | MP0005367_renal/urinary_system_phenotyp | 1.07918592 |
| 86 | MP0002332_abnormal_exercise_endurance | 1.07167741 |
| 87 | MP0008058_abnormal_DNA_repair | 1.06758930 |
| 88 | MP0000767_abnormal_smooth_muscle | 1.06526764 |
| 89 | MP0003221_abnormal_cardiomyocyte_apopto | 1.05520286 |
| 90 | MP0008057_abnormal_DNA_replication | 1.04694873 |
| 91 | MP0005076_abnormal_cell_differentiation | 1.03944723 |
| 92 | MP0005310_abnormal_salivary_gland | 1.02445141 |
| 93 | MP0009764_decreased_sensitivity_to | 1.01719704 |
| 94 | MP0003806_abnormal_nucleotide_metabolis | 1.01411927 |
| 95 | MP0005164_abnormal_response_to | 1.00696480 |
| 96 | MP0003718_maternal_effect | 0.99746625 |
| 97 | MP0005023_abnormal_wound_healing | 0.99084861 |
| 98 | MP0004147_increased_porphyrin_level | 0.97036937 |
| 99 | MP0001849_ear_inflammation | 0.96420531 |
| 100 | MP0010307_abnormal_tumor_latency | 0.96344607 |
| 101 | MP0003566_abnormal_cell_adhesion | 0.96155014 |
| 102 | MP0002933_joint_inflammation | 0.95525132 |
| 103 | MP0005501_abnormal_skin_physiology | 0.94342695 |
| 104 | MP0005166_decreased_susceptibility_to | 0.93169923 |
| 105 | MP0004272_abnormal_basement_membrane | 0.90452372 |
| 106 | MP0000313_abnormal_cell_death | 0.89693025 |
| 107 | MP0003303_peritoneal_inflammation | 0.89683191 |
| 108 | MP0005390_skeleton_phenotype | 0.86802064 |
| 109 | MP0002277_abnormal_respiratory_mucosa | 0.86567344 |
| 110 | MP0000350_abnormal_cell_proliferation | 0.85387289 |
| 111 | MP0009763_increased_sensitivity_to | 0.83418184 |
| 112 | MP0005165_increased_susceptibility_to | 0.82434443 |
| 113 | MP0000566_synostosis | 0.82332733 |
| 114 | MP0003795_abnormal_bone_structure | 0.81956192 |
| 115 | MP0005330_cardiomyopathy | 0.81437156 |
| 116 | MP0001727_abnormal_embryo_implantation | 0.80164852 |
| 117 | MP0000749_muscle_degeneration | 0.80141695 |
| 118 | MP0005410_abnormal_fertilization | 0.78969677 |
| 119 | MP0002060_abnormal_skin_morphology | 0.78910537 |
| 120 | MP0005058_abnormal_lysosome_morphology | 0.77222126 |
| 121 | MP0003183_abnormal_peptide_metabolism | 0.76667573 |
| 122 | MP0000747_muscle_weakness | 0.74403528 |
| 123 | MP0002282_abnormal_trachea_morphology | 0.72907233 |
| 124 | MP0004858_abnormal_nervous_system | 0.72743910 |
| 125 | MP0000358_abnormal_cell_content/ | 0.71012911 |
| 126 | MP0005319_abnormal_enzyme/_coenzyme | 0.70364659 |
| 127 | MP0003300_gastrointestinal_ulcer | 0.69871635 |
| 128 | MP0002098_abnormal_vibrissa_morphology | 0.69732400 |
| 129 | MP0003705_abnormal_hypodermis_morpholog | 0.69516255 |
| 130 | MP0001191_abnormal_skin_condition | 0.69142517 |
| 131 | MP0001216_abnormal_epidermal_layer | 0.68700842 |
| 132 | MP0001915_intracranial_hemorrhage | 0.68059105 |
| 133 | MP0010030_abnormal_orbit_morphology | 0.67973083 |
| 134 | MP0001119_abnormal_female_reproductive | 0.67935190 |
| 135 | MP0005083_abnormal_biliary_tract | 0.67793690 |
| 136 | MP0009384_cardiac_valve_regurgitation | 0.66600574 |
| 137 | MP0002998_abnormal_bone_remodeling | 0.66575360 |
| 138 | MP0008932_abnormal_embryonic_tissue | 0.66326550 |
| 139 | MP0003943_abnormal_hepatobiliary_system | 0.63918791 |
| 140 | MP0003786_premature_aging | 0.63701652 |
| 141 | MP0000477_abnormal_intestine_morphology | 0.62147784 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.81722232 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.81722232 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 4.81722232 |
| 4 | Vacuolated lymphocytes (HP:0001922) | 4.27099472 |
| 5 | Eczematoid dermatitis (HP:0000976) | 3.93853224 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.92867855 |
| 7 | Recurrent abscess formation (HP:0002722) | 3.80642703 |
| 8 | Axonal loss (HP:0003447) | 3.73945873 |
| 9 | Chronic otitis media (HP:0000389) | 3.46682315 |
| 10 | Loss of speech (HP:0002371) | 3.37401895 |
| 11 | Abnormal gallbladder physiology (HP:0012438) | 3.29517508 |
| 12 | Cholecystitis (HP:0001082) | 3.29517508 |
| 13 | Distal lower limb muscle weakness (HP:0009053) | 3.28928773 |
| 14 | Mediastinal lymphadenopathy (HP:0100721) | 3.27213913 |
| 15 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.24417200 |
| 16 | Recurrent cutaneous fungal infections (HP:0011370) | 3.24417200 |
| 17 | Abnormality of T cell number (HP:0011839) | 3.24282487 |
| 18 | Recurrent fungal infections (HP:0002841) | 3.21339851 |
| 19 | Recurrent viral infections (HP:0004429) | 3.20585656 |
| 20 | Recurrent bacterial skin infections (HP:0005406) | 3.20260884 |
| 21 | Combined immunodeficiency (HP:0005387) | 3.12166592 |
| 22 | T lymphocytopenia (HP:0005403) | 3.11118534 |
| 23 | Premature rupture of membranes (HP:0001788) | 3.09329340 |
| 24 | Increased IgM level (HP:0003496) | 3.09275627 |
| 25 | Dysostosis multiplex (HP:0000943) | 3.06783240 |
| 26 | Myositis (HP:0100614) | 3.03533817 |
| 27 | Autoimmune thrombocytopenia (HP:0001973) | 2.99693106 |
| 28 | Increased cerebral lipofuscin (HP:0011813) | 2.91097165 |
| 29 | Severe combined immunodeficiency (HP:0004430) | 2.88025191 |
| 30 | Reticulocytopenia (HP:0001896) | 2.83265505 |
| 31 | Recurrent skin infections (HP:0001581) | 2.82074631 |
| 32 | Petechiae (HP:0000967) | 2.78955087 |
| 33 | Granulocytopenia (HP:0001913) | 2.78392810 |
| 34 | Rough bone trabeculation (HP:0100670) | 2.77844989 |
| 35 | Abnormality of eosinophils (HP:0001879) | 2.74906143 |
| 36 | Abnormality of T cells (HP:0002843) | 2.70005697 |
| 37 | Eosinophilia (HP:0001880) | 2.69239966 |
| 38 | Prolonged neonatal jaundice (HP:0006579) | 2.68801661 |
| 39 | Abnormality of macrophages (HP:0004311) | 2.68647568 |
| 40 | Panhypogammaglobulinemia (HP:0003139) | 2.66181725 |
| 41 | Nasal polyposis (HP:0100582) | 2.65821287 |
| 42 | Leukocytosis (HP:0001974) | 2.65466338 |
| 43 | Systemic lupus erythematosus (HP:0002725) | 2.65359826 |
| 44 | Malnutrition (HP:0004395) | 2.65109128 |
| 45 | Recurrent bronchitis (HP:0002837) | 2.64189348 |
| 46 | Myocardial infarction (HP:0001658) | 2.63249102 |
| 47 | Nuclear cataract (HP:0100018) | 2.59117100 |
| 48 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.54683908 |
| 49 | Pustule (HP:0200039) | 2.54196304 |
| 50 | IgG deficiency (HP:0004315) | 2.53480484 |
| 51 | Stomatitis (HP:0010280) | 2.50883246 |
| 52 | Increased serum ferritin (HP:0003281) | 2.50513916 |
| 53 | Thrombocytosis (HP:0001894) | 2.49528328 |
| 54 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.47884169 |
| 55 | Abnormality of T cell physiology (HP:0011840) | 2.44124735 |
| 56 | Abnormal number of erythroid precursors (HP:0012131) | 2.43611266 |
| 57 | Orchitis (HP:0100796) | 2.40397492 |
| 58 | Abnormal trabecular bone morphology (HP:0100671) | 2.39629597 |
| 59 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.38112783 |
| 60 | Increased connective tissue (HP:0009025) | 2.37431911 |
| 61 | Diaphragmatic weakness (HP:0009113) | 2.37030529 |
| 62 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.36740611 |
| 63 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.36740611 |
| 64 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.36740611 |
| 65 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.35716083 |
| 66 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.35716083 |
| 67 | Single umbilical artery (HP:0001195) | 2.35716083 |
| 68 | Abnormality of the nasal mucosa (HP:0000433) | 2.35290330 |
| 69 | Cervical subluxation (HP:0003308) | 2.33567788 |
| 70 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.32071846 |
| 71 | Abnormality of the umbilical cord (HP:0010881) | 2.31704883 |
| 72 | J-shaped sella turcica (HP:0002680) | 2.27788569 |
| 73 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.25151423 |
| 74 | Meningitis (HP:0001287) | 2.24667320 |
| 75 | Thyroiditis (HP:0100646) | 2.24325501 |
| 76 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.24215858 |
| 77 | Cellulitis (HP:0100658) | 2.23607440 |
| 78 | Amyloidosis (HP:0011034) | 2.22265142 |
| 79 | Poikilocytosis (HP:0004447) | 2.21890234 |
| 80 | Hypoplasia of the thymus (HP:0000778) | 2.21416687 |
| 81 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.19077946 |
| 82 | Mucopolysacchariduria (HP:0008155) | 2.19077946 |
| 83 | IgM deficiency (HP:0002850) | 2.18497245 |
| 84 | Progressive neurologic deterioration (HP:0002344) | 2.14866254 |
| 85 | Agammaglobulinemia (HP:0004432) | 2.14654538 |
| 86 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.14015235 |
| 87 | Cleft eyelid (HP:0000625) | 2.13404433 |
| 88 | Generalized amyotrophy (HP:0003700) | 2.12729481 |
| 89 | Interstitial pulmonary disease (HP:0006530) | 2.10972287 |
| 90 | Abnormality of the prostate (HP:0008775) | 2.10186791 |
| 91 | Aplastic anemia (HP:0001915) | 2.09092266 |
| 92 | Nausea (HP:0002018) | 2.07839271 |
| 93 | Vertebral compression fractures (HP:0002953) | 2.07795465 |
| 94 | Urticaria (HP:0001025) | 2.07178610 |
| 95 | Poor head control (HP:0002421) | 2.06451127 |
| 96 | Popliteal pterygium (HP:0009756) | 2.05953015 |
| 97 | Retrobulbar optic neuritis (HP:0100654) | 2.05271212 |
| 98 | Optic neuritis (HP:0100653) | 2.05271212 |
| 99 | Hepatosplenomegaly (HP:0001433) | 2.03726147 |
| 100 | Muscle fiber atrophy (HP:0100295) | 2.03044160 |
| 101 | Ragged-red muscle fibers (HP:0003200) | 2.02863243 |
| 102 | Vasculitis (HP:0002633) | 2.01811353 |
| 103 | Micronodular cirrhosis (HP:0001413) | 1.99693057 |
| 104 | Bulbar palsy (HP:0001283) | 1.99276704 |
| 105 | Trismus (HP:0000211) | 1.98506952 |
| 106 | Microcytic anemia (HP:0001935) | 1.97785632 |
| 107 | IgA deficiency (HP:0002720) | 1.96816749 |
| 108 | Fatigue (HP:0012378) | 1.95367446 |
| 109 | Carpal bone hypoplasia (HP:0001498) | 1.93879048 |
| 110 | Mutism (HP:0002300) | 1.92333450 |
| 111 | Asymmetric septal hypertrophy (HP:0001670) | 1.92264735 |
| 112 | Spontaneous hematomas (HP:0007420) | 1.92053460 |
| 113 | Lymphoma (HP:0002665) | 1.92020229 |
| 114 | Hypertensive crisis (HP:0100735) | 1.91631934 |
| 115 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.90480483 |
| 116 | Hypergammaglobulinemia (HP:0010702) | 1.90252669 |
| 117 | Hemoptysis (HP:0002105) | 1.89438345 |
| 118 | Basal ganglia calcification (HP:0002135) | 1.88731059 |
| 119 | Hematochezia (HP:0002573) | 1.88447308 |
| 120 | Erythema (HP:0010783) | 1.88123713 |
| 121 | Purpura (HP:0000979) | 1.87694951 |
| 122 | Prostate neoplasm (HP:0100787) | 1.87224458 |
| 123 | Type 2 muscle fiber atrophy (HP:0003554) | 1.86207378 |
| 124 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.85475373 |
| 125 | Colon cancer (HP:0003003) | 1.85038403 |
| 126 | Osteolytic defects of the hand bones (HP:0009699) | 1.84549161 |
| 127 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.84549161 |
| 128 | Deformed sella turcica (HP:0002681) | 1.84434298 |
| 129 | Upper limb amyotrophy (HP:0009129) | 1.83595142 |
| 130 | Distal upper limb amyotrophy (HP:0007149) | 1.83595142 |
| 131 | Progressive muscle weakness (HP:0003323) | 1.83418326 |
| 132 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.83065579 |
| 133 | Autoimmune hemolytic anemia (HP:0001890) | 1.82386463 |
| 134 | Chronic obstructive pulmonary disease (HP:0006510) | 1.81035702 |
| 135 | Obstructive lung disease (HP:0006536) | 1.81035702 |
| 136 | Gingivitis (HP:0000230) | 1.79894498 |
| 137 | Difficulty climbing stairs (HP:0003551) | 1.79417021 |
| 138 | Exertional dyspnea (HP:0002875) | 1.79228470 |
| 139 | Cheilitis (HP:0100825) | 1.78001963 |
| 140 | Hypochromic anemia (HP:0001931) | 1.76652700 |
| 141 | Distal lower limb amyotrophy (HP:0008944) | 1.75481534 |
| 142 | Abnormality of reticulocytes (HP:0004312) | 1.74493496 |
| 143 | Short nail (HP:0001799) | 1.74336706 |
| 144 | Skin ulcer (HP:0200042) | 1.74276957 |
| 145 | Encephalitis (HP:0002383) | 1.73977465 |
| 146 | Keratoconjunctivitis sicca (HP:0001097) | 1.73909657 |
| 147 | Pallor (HP:0000980) | 1.73828119 |
| 148 | Cutaneous photosensitivity (HP:0000992) | 1.73578147 |
| 149 | Nonimmune hydrops fetalis (HP:0001790) | 1.72941636 |
| 150 | Macrocytic anemia (HP:0001972) | 1.72565583 |
| 151 | Reduced antithrombin III activity (HP:0001976) | 1.72525847 |
| 152 | Muscle fibrillation (HP:0010546) | 1.72508911 |
| 153 | Recurrent lower respiratory tract infections (HP:0002783) | 1.72077382 |
| 154 | Small epiphyses (HP:0010585) | 1.71828347 |
| 155 | Upper motor neuron abnormality (HP:0002127) | 1.71727447 |
| 156 | Hand muscle atrophy (HP:0009130) | 1.70906029 |
| 157 | Neutropenia (HP:0001875) | 1.70805522 |
| 158 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.69578083 |
| 159 | Parakeratosis (HP:0001036) | 1.68557644 |
| 160 | Breast hypoplasia (HP:0003187) | 1.68059953 |
| 161 | Skin rash (HP:0000988) | 1.67780023 |
| 162 | Recurrent pneumonia (HP:0006532) | 1.67255487 |
| 163 | Osteomyelitis (HP:0002754) | 1.66665802 |
| 164 | Disinhibition (HP:0000734) | 1.66386356 |
| 165 | Bone pain (HP:0002653) | 1.65647529 |
| 166 | Dilatation of the ascending aorta (HP:0005111) | 1.65239498 |
| 167 | Abnormality of iron homeostasis (HP:0011031) | 1.64784388 |
| 168 | Hypokinesia (HP:0002375) | 1.64497856 |
| 169 | Ankle contracture (HP:0006466) | 1.63436292 |
| 170 | Achilles tendon contracture (HP:0001771) | 1.63375496 |
| 171 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.61223373 |
| 172 | Myopathic facies (HP:0002058) | 1.60543613 |
| 173 | Fasciculations (HP:0002380) | 1.59912696 |
| 174 | Spinal rigidity (HP:0003306) | 1.58503097 |
| 175 | Shoulder girdle muscle weakness (HP:0003547) | 1.57052478 |
| 176 | Degeneration of anterior horn cells (HP:0002398) | 1.55134095 |
| 177 | Abnormality of the anterior horn cell (HP:0006802) | 1.55134095 |
| 178 | Protrusio acetabuli (HP:0003179) | 1.55132367 |
| 179 | Hypoplastic left heart (HP:0004383) | 1.55002807 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K3 | 3.40989604 |
| 2 | EPHA2 | 2.61905682 |
| 3 | TRIB3 | 2.43371356 |
| 4 | IRAK4 | 2.31209338 |
| 5 | PIM2 | 2.29982846 |
| 6 | MAP4K1 | 2.25002322 |
| 7 | TYK2 | 2.24700014 |
| 8 | VRK2 | 2.20419131 |
| 9 | TAOK2 | 2.17708120 |
| 10 | JAK3 | 2.13026832 |
| 11 | MAP3K14 | 2.07402324 |
| 12 | PRPF4B | 2.02725013 |
| 13 | IKBKE | 2.02112826 |
| 14 | TLK1 | 2.00414288 |
| 15 | STK10 | 1.94630526 |
| 16 | TBK1 | 1.92846731 |
| 17 | KIT | 1.87841880 |
| 18 | BUB1 | 1.87202203 |
| 19 | CLK1 | 1.85452407 |
| 20 | TESK2 | 1.84667411 |
| 21 | SIK1 | 1.83112740 |
| 22 | NLK | 1.82197608 |
| 23 | NME2 | 1.75180823 |
| 24 | STK4 | 1.73263284 |
| 25 | BLK | 1.70391817 |
| 26 | SIK3 | 1.69901451 |
| 27 | PBK | 1.67807500 |
| 28 | FGFR4 | 1.64436811 |
| 29 | ERN1 | 1.60955554 |
| 30 | IKBKB | 1.59919753 |
| 31 | EIF2AK1 | 1.55786002 |
| 32 | IRAK3 | 1.55038610 |
| 33 | SMG1 | 1.48879271 |
| 34 | PIM1 | 1.47210688 |
| 35 | TXK | 1.45611331 |
| 36 | MST4 | 1.44841076 |
| 37 | TAOK1 | 1.43837095 |
| 38 | EPHB1 | 1.40240073 |
| 39 | BTK | 1.36046228 |
| 40 | MAP3K10 | 1.34940553 |
| 41 | TAOK3 | 1.31298673 |
| 42 | RPS6KA4 | 1.26315269 |
| 43 | VRK1 | 1.25863884 |
| 44 | MELK | 1.25573299 |
| 45 | PDK2 | 1.25453316 |
| 46 | KDR | 1.24430503 |
| 47 | DDR2 | 1.22182852 |
| 48 | CHUK | 1.20611727 |
| 49 | LIMK1 | 1.15984912 |
| 50 | MAP3K2 | 1.14379982 |
| 51 | TEC | 1.13081962 |
| 52 | MAPK11 | 1.11182046 |
| 53 | NEK9 | 1.08507191 |
| 54 | CSK | 1.06473521 |
| 55 | RPS6KA5 | 1.06345408 |
| 56 | TRPM7 | 1.05121550 |
| 57 | STK16 | 1.03891146 |
| 58 | RPS6KB2 | 1.03258649 |
| 59 | MYLK | 1.02297068 |
| 60 | JAK1 | 1.00848154 |
| 61 | MAP3K12 | 1.00095400 |
| 62 | LRRK2 | 0.98519894 |
| 63 | MATK | 0.98393002 |
| 64 | ZAK | 0.98172858 |
| 65 | MAP3K8 | 0.96526314 |
| 66 | ITK | 0.96185326 |
| 67 | MAP3K1 | 0.95675490 |
| 68 | TTK | 0.95489124 |
| 69 | ILK | 0.95105672 |
| 70 | NEK2 | 0.92562893 |
| 71 | TGFBR2 | 0.91164223 |
| 72 | KSR2 | 0.91071226 |
| 73 | FRK | 0.90227346 |
| 74 | ZAP70 | 0.89345650 |
| 75 | MAP3K11 | 0.89235361 |
| 76 | MAP2K3 | 0.88238562 |
| 77 | BMPR2 | 0.86174998 |
| 78 | PASK | 0.84237185 |
| 79 | FGR | 0.82874508 |
| 80 | GRK6 | 0.80328905 |
| 81 | FGFR3 | 0.80316355 |
| 82 | PLK1 | 0.79754577 |
| 83 | MARK3 | 0.79536478 |
| 84 | ABL2 | 0.79462594 |
| 85 | LYN | 0.79165168 |
| 86 | CDK6 | 0.78297411 |
| 87 | LCK | 0.75941160 |
| 88 | SYK | 0.75547841 |
| 89 | AURKB | 0.75461439 |
| 90 | BMX | 0.74749154 |
| 91 | PKN2 | 0.74555742 |
| 92 | TTN | 0.74089381 |
| 93 | TESK1 | 0.73360334 |
| 94 | WEE1 | 0.73211772 |
| 95 | CDK4 | 0.73118295 |
| 96 | RIPK4 | 0.72910870 |
| 97 | LATS2 | 0.72413876 |
| 98 | GRK7 | 0.71716005 |
| 99 | DYRK3 | 0.70523244 |
| 100 | IRAK2 | 0.66450500 |
| 101 | PLK4 | 0.66265389 |
| 102 | ERBB4 | 0.65404609 |
| 103 | EIF2AK3 | 0.64250582 |
| 104 | CDC7 | 0.62444371 |
| 105 | MAPKAPK2 | 0.61936808 |
| 106 | ARAF | 0.61233672 |
| 107 | EPHA3 | 0.60103368 |
| 108 | MAP3K5 | 0.60004002 |
| 109 | PAK4 | 0.59287650 |
| 110 | JAK2 | 0.59184257 |
| 111 | PDPK1 | 0.58899417 |
| 112 | CDK7 | 0.58871120 |
| 113 | ATR | 0.58562768 |
| 114 | MST1R | 0.58521668 |
| 115 | CSF1R | 0.58195701 |
| 116 | SRPK1 | 0.57868609 |
| 117 | BRSK2 | 0.57340043 |
| 118 | PAK1 | 0.57185170 |
| 119 | MAPKAPK3 | 0.56891979 |
| 120 | IRAK1 | 0.55902362 |
| 121 | STK24 | 0.55766177 |
| 122 | DYRK1B | 0.55431864 |
| 123 | PRKD2 | 0.55210343 |
| 124 | SCYL2 | 0.54959898 |
| 125 | BCKDK | 0.54319094 |
| 126 | PRKG2 | 0.54159444 |
| 127 | PRKCI | 0.54081056 |
| 128 | EPHB2 | 0.53644199 |
| 129 | MAP2K2 | 0.52569753 |
| 130 | RIPK1 | 0.52478068 |
| 131 | FLT3 | 0.50740894 |
| 132 | MAP3K13 | 0.50511416 |
| 133 | PTK6 | 0.50502132 |
| 134 | PTK2 | 0.50039427 |
| 135 | BRSK1 | 0.49813606 |
| 136 | TRIM28 | 0.49279250 |
| 137 | DAPK3 | 0.47853285 |
| 138 | STK3 | 0.47662519 |
| 139 | BRAF | 0.47174236 |
| 140 | CDK8 | 0.47172822 |
| 141 | YES1 | 0.46645774 |
| 142 | RAF1 | 0.44544039 |
| 143 | CDK9 | 0.43880038 |
| 144 | ACVR1B | 0.43590675 |
| 145 | NEK6 | 0.43489233 |
| 146 | MOS | 0.41623448 |
| 147 | CDC42BPA | 0.40599861 |
| 148 | RPS6KC1 | 0.38899800 |
| 149 | RPS6KL1 | 0.38899800 |
| 150 | LMTK2 | 0.37873840 |
| 151 | MAPK15 | 0.37872513 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 2.53225661 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.50708600 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 2.47832674 |
| 4 | Proteasome_Homo sapiens_hsa03050 | 2.47109383 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.25694294 |
| 6 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.24555239 |
| 7 | Mismatch repair_Homo sapiens_hsa03430 | 1.98245445 |
| 8 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.94086961 |
| 9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.92838010 |
| 10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.92041353 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.86485005 |
| 12 | Galactose metabolism_Homo sapiens_hsa00052 | 1.73343480 |
| 13 | Malaria_Homo sapiens_hsa05144 | 1.72515767 |
| 14 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.71181005 |
| 15 | Base excision repair_Homo sapiens_hsa03410 | 1.67640504 |
| 16 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.65620912 |
| 17 | Allograft rejection_Homo sapiens_hsa05330 | 1.65545791 |
| 18 | Cell cycle_Homo sapiens_hsa04110 | 1.65379923 |
| 19 | Leishmaniasis_Homo sapiens_hsa05140 | 1.64063911 |
| 20 | Homologous recombination_Homo sapiens_hsa03440 | 1.63692800 |
| 21 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.61191823 |
| 22 | Measles_Homo sapiens_hsa05162 | 1.60599519 |
| 23 | RNA polymerase_Homo sapiens_hsa03020 | 1.57267542 |
| 24 | Protein export_Homo sapiens_hsa03060 | 1.50127300 |
| 25 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.46853088 |
| 26 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.45772614 |
| 27 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.42336677 |
| 28 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.41621509 |
| 29 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.36993362 |
| 30 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.35510870 |
| 31 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.34991904 |
| 32 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.34150931 |
| 33 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.34125632 |
| 34 | Legionellosis_Homo sapiens_hsa05134 | 1.33655153 |
| 35 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.33353462 |
| 36 | Basal transcription factors_Homo sapiens_hsa03022 | 1.32986843 |
| 37 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.32013365 |
| 38 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.28881843 |
| 39 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.23631071 |
| 40 | Spliceosome_Homo sapiens_hsa03040 | 1.22170017 |
| 41 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.19833187 |
| 42 | Sulfur relay system_Homo sapiens_hsa04122 | 1.19446639 |
| 43 | Apoptosis_Homo sapiens_hsa04210 | 1.18008273 |
| 44 | Salmonella infection_Homo sapiens_hsa05132 | 1.16532613 |
| 45 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.11761931 |
| 46 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.11115693 |
| 47 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.10168709 |
| 48 | RNA degradation_Homo sapiens_hsa03018 | 1.08517852 |
| 49 | Shigellosis_Homo sapiens_hsa05131 | 1.07606021 |
| 50 | Influenza A_Homo sapiens_hsa05164 | 1.03918236 |
| 51 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.02583130 |
| 52 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.02564423 |
| 53 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.02433747 |
| 54 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.01668792 |
| 55 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.01315442 |
| 56 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.99506837 |
| 57 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.98526832 |
| 58 | Hepatitis B_Homo sapiens_hsa05161 | 0.97616352 |
| 59 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.97559456 |
| 60 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.96857290 |
| 61 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.95138091 |
| 62 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.93466377 |
| 63 | Amoebiasis_Homo sapiens_hsa05146 | 0.92947278 |
| 64 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.91700513 |
| 65 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.89572411 |
| 66 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.89335549 |
| 67 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.88347398 |
| 68 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.87881889 |
| 69 | Viral myocarditis_Homo sapiens_hsa05416 | 0.86853971 |
| 70 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.86336785 |
| 71 | RNA transport_Homo sapiens_hsa03013 | 0.84686632 |
| 72 | Pertussis_Homo sapiens_hsa05133 | 0.84383939 |
| 73 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.82867966 |
| 74 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.82353912 |
| 75 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.82235332 |
| 76 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.80041757 |
| 77 | Endocytosis_Homo sapiens_hsa04144 | 0.78164345 |
| 78 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.78073923 |
| 79 | HTLV-I infection_Homo sapiens_hsa05166 | 0.76536884 |
| 80 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.75384463 |
| 81 | Asthma_Homo sapiens_hsa05310 | 0.75286094 |
| 82 | Tuberculosis_Homo sapiens_hsa05152 | 0.75238600 |
| 83 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.75208072 |
| 84 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.74993700 |
| 85 | Thyroid cancer_Homo sapiens_hsa05216 | 0.74692004 |
| 86 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.74526141 |
| 87 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.74239100 |
| 88 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.74034041 |
| 89 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.71745342 |
| 90 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.71554809 |
| 91 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.70139230 |
| 92 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.69856886 |
| 93 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.69462527 |
| 94 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.69160839 |
| 95 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.68870909 |
| 96 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.68509527 |
| 97 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.67130039 |
| 98 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.65955487 |
| 99 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.63993987 |
| 100 | Hepatitis C_Homo sapiens_hsa05160 | 0.63974873 |
| 101 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.63098992 |
| 102 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.62863230 |
| 103 | Other glycan degradation_Homo sapiens_hsa00511 | 0.62248146 |
| 104 | Carbon metabolism_Homo sapiens_hsa01200 | 0.59662398 |
| 105 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.59638442 |
| 106 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.59611526 |
| 107 | Prion diseases_Homo sapiens_hsa05020 | 0.58122051 |
| 108 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.57768161 |
| 109 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.57629891 |
| 110 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.57473877 |
| 111 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.56817227 |
| 112 | Histidine metabolism_Homo sapiens_hsa00340 | 0.56646371 |
| 113 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.56333929 |
| 114 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.55215218 |
| 115 | Bladder cancer_Homo sapiens_hsa05219 | 0.51588120 |
| 116 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.51488620 |
| 117 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.51369288 |
| 118 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.48697422 |
| 119 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.48678965 |
| 120 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.48484120 |
| 121 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.48140670 |
| 122 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.47369891 |
| 123 | Phagosome_Homo sapiens_hsa04145 | 0.46580634 |
| 124 | Purine metabolism_Homo sapiens_hsa00230 | 0.45429616 |
| 125 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.45283200 |
| 126 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.44686186 |
| 127 | Lysosome_Homo sapiens_hsa04142 | 0.43294329 |
| 128 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.42471009 |
| 129 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.41731283 |
| 130 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.41722939 |
| 131 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.41692201 |
| 132 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.41257887 |
| 133 | Endometrial cancer_Homo sapiens_hsa05213 | 0.40835225 |
| 134 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.40035979 |

